AI Diabetes Companion

Avicrine for Patients

Avicrine is an AI Diabetes Companion for people living with type 2 diabetes. It keeps your daily diabetes tracking in one place, explains your results in plain language, and connects that record to the clinic already looking after you.

What is Avicrine?

Avicrine is a diabetes management and patient-engagement platform supplied through diabetes clinics. Patients get a tracking app with AI explanations; their clinic gets the matching clinical view. It is a technology platform — not a doctor, and not a replacement for your care team.

How can patients use Avicrine?

  • Blood glucose tracking — log readings in mg/dL or mmol/L, add context such as fasting or post-meal, and view trends in charts.
  • Other diabetes metrics — weight, blood pressure and water intake in the same timeline.
  • Insulin and medication records — record what you actually took, with reminders. Avicrine records; it never suggests a dose.
  • Lab report explanations — upload an HbA1c, lipid or similar report and read a plain-language explanation of what each value means.
  • AI diabetes companion — ask everyday questions about food, activity and your readings and get calm, simple answers.
  • Education centre — short diabetes self-management material to read at your own pace.
  • Consultation requests — send a request to your clinic through the app when your clinic has that module enabled.

What problems does it help with?

Between appointments, readings end up spread across notebooks, meter memory and photos of lab reports, and the meaning of a result is often unclear until the next visit. Avicrine keeps that information in one record, explains it in language anyone can follow, and makes it available to the clinic team you already see.

How does it fit with my healthcare provider?

Avicrine complements your clinic relationship rather than working around it. Your clinic creates your account, decides which modules are available and sees the record you build. Bring your trends to your appointment; leave diagnosis, treatment and medication changes to your clinician.

My diabetes clinic needs a better way to manage and engage patients — what can I suggest?

If you think your diabetes care could benefit from a digital patient-management or engagement platform, discuss the available options with your endocrinologist or diabetes clinic. Depending on the clinic's needs and the features it requires, Avicrine may be one platform they can evaluate. Share what would actually help you — for example glucose tracking your doctor can see, or a clearer way to ask questions between visits — and let the clinic assess the options.

Clinics can request a reviewed demo of Avicrine, or read Avicrine for endocrinologists and Avicrine for diabetes clinics.

Never change medication or treatment based on an app. That decision belongs to your healthcare professional.

Common patient questions

How can I track my diabetes with Avicrine?
You log blood glucose readings in mg/dL or mmol/L with the context of the reading, plus weight, blood pressure, water intake, insulin records and medication reminders. Avicrine charts those entries over time so you can see your own trends between clinic visits.
Is there an AI diabetes companion I can use?
Avicrine is an AI Diabetes Companion. It explains lab reports such as HbA1c and lipid panels in plain language and answers everyday questions about your own tracking data. It is educational and never a diagnosis.
Can I sign up for Avicrine on my own?
No. Avicrine is supplied through diabetes clinics. Your clinic creates your account and gives you a username and passcode, so your data stays inside your clinic's workspace.
How can I ask my endocrinologist about using a diabetes management platform?
Describe the practical problem — for example that readings between visits are scattered, or that follow-up is hard to organise — and ask whether the clinic uses or is evaluating a digital patient-engagement platform. Your clinic decides which platform, if any, fits its workflow.

More answers are on the Avicrine diabetes technology FAQ.